Report Summary

AxoGen, Inc.(AxoGen) is engaged in the development, manufacture and marketing of surgical implants for the neurology markets. The company develops peripheral nerve regeneration technologies to repair and regenerate peripheral nerves. The company’s AVANCE Nerve Grafts are used by surgeons to repair and regenerate peripheral nerves. It is an human allograft which is minimally processed to preserve the three dimensional structure and growth promoters and the resulting nerve graft provides nerve regeneration without immunosuppresion. The company has strategic partnership with LifeNet Health. It is headquartered in Florida, United States

The AxoGen, Inc. - Medical Equipment - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company’s major recent financial deals.

Scope

- Provides key company information for business intelligence needs
- Gives information on the company’s major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.

Reasons to buy

- A quick "one-stop-shop" to understand the company.
- Support sales activities by understanding your customers’ businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors’ business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.